טוען...
Are we optimizing the use of dual antiplatelet therapy in patients hospitalized with acute myocardial infarction?
BACKGROUND: Dual antiplatelet therapy (DAPT) is a mainstay treatment for hospital survivors of an acute myocardial infarction (AMI). However, there are limited data on the prescribing patterns of DAPT among patients hospitalized with AMI during recent years. OBJECTIVE: To examine decade-long trends...
שמור ב:
| הוצא לאור ב: | Cardiovasc Revasc Med |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6824980/ https://ncbi.nlm.nih.gov/pubmed/31129036 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.carrev.2019.04.024 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|